A drugmaker is recalling a product used to treat patients with Type 2 diabetes due to possible contamination with a potentially cancer-causing compound.
A drugmaker is recalling a product used to treat patients with Type 2 diabetes due to possible contamination with a potentially cancer-causing compound.
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
We'll send a verification code to %EMAIL%.
Get the best of The Washington Informer directly in your email inbox.
Sending to: